Promoter targeting of chromatin-modifying complexes

被引:120
|
作者
Hassan, AH
Neely, KE
Vignali, M
Reese, JC
Workman, JL
机构
[1] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA
[2] Univ Washington, Dept Genet, Seattle, WA 98195 USA
[3] Univ Washington, Dept Med, Seattle, WA 98195 USA
来源
关键词
promoter targeting; activators; repressors; SWI; SNF/HATs; HDACs; bromodomains; review;
D O I
10.2741/Hassan
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The action of multi-subunit complexes that are able to overcome the repressive effects of chromatin is an important step in the regulation of eukaryotic gene expression. Identification of complexes that modify the structure of chromatin to help factors access the underlying DNA has enhanced our understanding of how some genes are controlled. Histone acetyltransferases (HATs) and histone deacetylases (HDACs) represent one group of complexes that regulate the level of acetylation on the N-terminal tails of core histone proteins. The SWI/SNF complex is the prototype of a second group of complexes, which use the energy of ATP-hydrolysis to alter histone-DNA contacts, leading to changes in chromatin conformation. Genetic studies in yeast have revealed that some of these multi-subunit complexes interact in vivo to control transcription of a subset of genes. It has become apparent that some gene promoters require modifications by both types of complexes. An important question regarding these two types of complexes is how they are recruited to the promoters of genes that are dependent on their activity for their expression. This review will tie together many studies on promoter recruitment of both HATs and SWI/SNF. Emphasis will be placed on recent data that demonstrates functional interplay between these two types of chromatin-remodeling activities. In addition, this review summarizes recent data demonstrating the ability of repressors and corepressors to recruit histone deacetylase complexes. Interestingly, many subunits of chromatin-modifying complexes in humans have been implicated in the development of cancer. Thus, studying how these complexes work can help us better understand human diseases.
引用
收藏
页码:D1054 / D1064
页数:11
相关论文
共 50 条
  • [21] Rational for targeting chromatin-modifying genes in clear-cell renal cell carcinomas
    Malouf, G.
    Zhang, J.
    Khayat, D.
    Su, X.
    Spano, J. R.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 188 - 188
  • [22] Probing Chromatin-modifying Enzymes with Chemical Tools
    Fischle, Wolfgang
    Schwarzer, Dirk
    ACS CHEMICAL BIOLOGY, 2016, 11 (03) : 689 - 705
  • [23] Binding Profiles of Chromatin-Modifying Proteins Are Predictive for Transcriptional Activity and Promoter-Proximal Pausing
    Sakoparnig, Thomas
    Kockmann, Tobias
    Paro, Renato
    Beisel, Christian
    Beerenwinkel, Niko
    JOURNAL OF COMPUTATIONAL BIOLOGY, 2012, 19 (02) : 126 - 138
  • [24] How do ncRNAs guide chromatin-modifying complexes to specific locations within the nucleus?
    Scott, Maxwell J.
    Li, Fang
    RNA BIOLOGY, 2008, 5 (01) : 13 - 16
  • [25] Neuronal necrosis is regulated by a conserved chromatin-modifying cascade
    Liu, Kai
    Ding, Lianggong
    Li, Yuhong
    Yang, Hui
    Zhao, Chunyue
    Lei, Ye
    Han, Shuting
    Tao, Wei
    Miao, Dengshun
    Steller, Hermann
    Welsh, Michael J.
    Liu, Lei
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (38) : 13960 - 13965
  • [26] Targeting chromatin modifying complexes in acute myeloid leukemia
    Schurer, Alexandra
    Glushakow-Smith, Shira G.
    Gritsman, Kira
    STEM CELLS TRANSLATIONAL MEDICINE, 2024,
  • [27] Chromatin-modifying enzymes as therapeutic targets - Part 1
    Keppler, Brian R.
    Archer, Trevor K.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (10) : 1301 - 1312
  • [28] Chromatin-modifying agents in anti-cancer therapy
    Seidel, Carole
    Florean, Cristina
    Schnekenburger, Michael
    Dicato, Mario
    Diederich, Marc
    BIOCHIMIE, 2012, 94 (11) : 2264 - 2279
  • [29] Chromatin-modifying drugs and metabolites in cell fate control
    Yao, Ziyue
    Chen, Yu
    Cao, Wenhua
    Shyh-Chang, Ng
    CELL PROLIFERATION, 2020, 53 (11)
  • [30] Approaches to Study Native Chromatin-Modifying Complex Activities and Functions
    Galloy, Maxime
    Lachance, Catherine
    Cheng, Xue
    Distefano-Gagne, Felix
    Cote, Jacques
    Fradet-Turcotte, Amelie
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9